dehydroepiandrosterone has been researched along with 2019 Novel Coronavirus Disease in 9 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomo, S | 2 |
| Banerjee, M | 2 |
| Sharma, P | 2 |
| Garg, M | 1 |
| Papadopoulos, KI | 1 |
| Papadopoulou, A | 1 |
| Sutheesophon, W | 1 |
| Aw, TC | 1 |
| Karli, S | 1 |
| Purohit, P | 1 |
| Mitra, P | 1 |
| Garg, MK | 1 |
| Kumar, B | 1 |
| Kolatorova, L | 1 |
| Adamcova, K | 1 |
| Vitku, J | 1 |
| Horackova, L | 1 |
| Simkova, M | 1 |
| Hornova, M | 1 |
| Vosatkova, M | 1 |
| Vaisova, V | 1 |
| Parizek, A | 1 |
| Duskova, M | 1 |
| Yavropoulou, MP | 1 |
| Sfikakis, PP | 1 |
| Falco, A | 1 |
| Girardi, D | 1 |
| Elfering, A | 1 |
| Peric, T | 1 |
| Pividori, I | 1 |
| Dal Corso, L | 1 |
| Guzman, JM | 1 |
| Boone, MH | 1 |
| Suarez, GL | 1 |
| Mitchell, C | 1 |
| Monk, CS | 1 |
| Hyde, LW | 1 |
| Lopez-Duran, NL | 1 |
| Semenova, NV | 1 |
| Vyrupaeva, EV | 1 |
| Kolesnikov, SI | 1 |
| Sholokhov, LF | 1 |
| Rychkova, LV | 1 |
| Petrova, AG | 1 |
| Akhmedzyanova, MR | 1 |
| Darenskaya, MA | 1 |
| Kolesnikova, LI | 1 |
| Nyce, J | 1 |
2 reviews available for dehydroepiandrosterone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?
Topics: COVID-19; COVID-19 Drug Treatment; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; H | 2021 |
Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19.
Topics: Androgens; Animals; COVID-19; Dehydroepiandrosterone; Female; Humans; Male; Nonprescription Drugs; S | 2021 |
7 other studies available for dehydroepiandrosterone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; COVID-19; Dehydroepiandrosteron | 2022 |
Assessment of DHEAS, cortisol, and DHEAS/cortisol ratio in patients with COVID-19: a pilot study.
Topics: COVID-19; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Pilot Proj | 2022 |
COVID-19, Vaccination, and Female Fertility in the Czech Republic.
Topics: 20-alpha-Dihydroprogesterone; Androgens; Animals; Anti-Mullerian Hormone; COVID-19; COVID-19 Vaccine | 2022 |
Cortisol and DHEAS in COVID-19.
Topics: COVID-19; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone | 2023 |
Is Smart Working Beneficial for Workers' Wellbeing? A Longitudinal Investigation of Smart Working, Workload, and Hair Cortisol/Dehydroepiandrosterone Sulfate during the COVID-19 Pandemic.
Topics: Biomarkers; COVID-19; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Hair; Humans; Hydrocor | 2023 |
Relationship between COVID-related stressors and internalizing symptoms: Gendered neuroendocrine risk profiles.
Topics: Adolescent; Adult; COVID-19; Dehydroepiandrosterone; Female; Humans; Hydrocortisone; Hypothalamo-Hyp | 2024 |
[Neuroendocrine changes among 45-60 years old women with COVID-19 and 12 months after the disease.]
Topics: COVID-19; Dehydroepiandrosterone; Estradiol; Female; Humans; Hydrocortisone; Male; Progesterone; Pro | 2023 |